FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012036721> ?p ?o ?g. }

• W2012036721 endingPage "11" @default.
• W2012036721 startingPage "9" @default.
• W2012036721 abstract "Pain ManagementVol. 4, No. 1 EditorialMinimizing immunosuppression: an alternative approach for anesthesiologists?Maria Fernanda RamirezPeter TranJuan Pablo CataMaria Fernanda RamirezSearch for more papers by this authorPeter TranSearch for more papers by this authorJuan Pablo Cata* Author for correspondenceDepartment of Anesthesiology & Perioperative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard 77030, Houston, TX, USA. Search for more papers by this authorEmail the corresponding author at jcata@mdanderson.orgPublished Online:19 Dec 2013https://doi.org/10.2217/pmt.13.67AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleReferences1 Cata JP, Gottumukkala V, Sessler DI. How regional analgesia might reduce postoperative cancer recurrence. Eur. J. Pain Suppl.5,345–355 (2011).Crossref, CAS, Google Scholar2 Naruse T, Nishida Y, Hosono K, Ishiguro N. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis27,584–592 (2006).Crossref, Medline, CAS, Google Scholar3 Ishikawa M, Nishioka M, Hanaki N et al. Perioperative immune responses in cancer patients undergoing digestive surgeries. World J. Surg. Oncol.7,7 (2009).Crossref, Medline, Google Scholar4 Cata JP, Bauer M, Sokari T et al. Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer. J. Clin. Anesth.25(4),255–262 (2013).Crossref, Medline, CAS, Google Scholar5 Mitsuhata H, Shimizu R, Yokoyama MM. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int. J. Immunopharmacol.17,529–534 (1995).Crossref, Medline, CAS, Google Scholar6 Woods GM, Griffiths DM. Reversible inhibition of natural killer cell activity by volatile anaesthetic agents in vitro. Br. J. Anaesth.58,535–539 (1986).Crossref, Medline, CAS, Google Scholar7 Mammoto T, Mukai M, Mammoto A et al. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett.184,165–170 (2002).Crossref, Medline, CAS, Google Scholar8 Gupta K, Kshirsagar S, Chang L et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res.62,4491–4498 (2002).Medline, CAS, Google Scholar9 Lazarczyk M, Matyja E, Lipkowski AW. A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro. Peptides31,1606–1612 (2010).Crossref, Medline, CAS, Google Scholar10 Hernandez MC, Flores LR, Bayer BM. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther.267,1336–1341 (1993).Medline, CAS, Google Scholar11 Franchi S, Panerai AE, Sacerdote P. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav. Immun.21,767–774 (2007).Crossref, Medline, CAS, Google Scholar12 Mammoto T, Higashiyama S, Mukai M et al. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). J. Cell Physiol.192,351–358 (2002).Crossref, Medline, CAS, Google Scholar13 Koltun WA, Bloomer MM, Tilberg AF et al. Awake epidural anesthesia is associated with improved natural killer cell cytotoxicity and a reduced stress response. Am. J. Surg.171,68–72, discussion 72–63 (1996).Crossref, Medline, CAS, Google Scholar14 Cardinale F, Chinellato I, Caimmi S et al. Perioperative period: immunological modifications. Int. J. Immunopathol. Pharmacol.24,S3–S12 (2011).Crossref, Medline, CAS, Google Scholar15 Yokoyama M, Itano Y, Katayama H et al. The effects of continuous epidural anesthesia and analgesia on stress response and immune function in patients undergoing radical esophagectomy. Anesth. Analg.101,1521–1527 (2005).Crossref, Medline, CAS, Google Scholar16 Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology105,660–664 (2006).Crossref, Medline, Google Scholar17 Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology109,180–187 (2008).Crossref, Medline, Google Scholar18 Cummings KC, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology116,797–806 (2012).Crossref, Medline, CAS, Google Scholar19 Gottschalk A, Ford JG, Regelin CC et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology113,27–34 (2010).Crossref, Medline, Google Scholar20 Chen WK, Miao CH. The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies. PLoS ONE8,e56540 (2013).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByThe role of opioids in cancer progression3 February 2020 | International Anesthesiology Clinics, Vol. 58, No. 2 Vol. 4, No. 1 Follow us on social media for the latest updates Metrics Downloaded 62 times History Published online 19 December 2013 Published in print January 2014 Information© Future Medicine LtdFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W2012036721 created "2016-06-24" @default.
• W2012036721 creator A5025645999 @default.
• W2012036721 creator A5053374206 @default.
• W2012036721 creator A5072599343 @default.
• W2012036721 date "2014-01-01" @default.
• W2012036721 modified "2023-10-18" @default.
• W2012036721 title "Minimizing immunosuppression: an alternative approach for anesthesiologists?" @default.
• W2012036721 cites W1964375059 @default.
• W2012036721 cites W1985979682 @default.
• W2012036721 cites W1986629773 @default.
• W2012036721 cites W1994525571 @default.
• W2012036721 cites W1994769891 @default.
• W2012036721 cites W2006975316 @default.
• W2012036721 cites W2007577818 @default.
• W2012036721 cites W2010496961 @default.
• W2012036721 cites W2016451492 @default.
• W2012036721 cites W2039708852 @default.
• W2012036721 cites W2039911822 @default.
• W2012036721 cites W2048894064 @default.
• W2012036721 cites W2056341285 @default.
• W2012036721 cites W2068203282 @default.
• W2012036721 cites W2081806604 @default.
• W2012036721 cites W2099318069 @default.
• W2012036721 cites W2111866947 @default.
• W2012036721 cites W2399055434 @default.
• W2012036721 doi "https://doi.org/10.2217/pmt.13.67" @default.
• W2012036721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24641336" @default.
• W2012036721 hasPublicationYear "2014" @default.
• W2012036721 type Work @default.
• W2012036721 sameAs 2012036721 @default.
• W2012036721 citedByCount "1" @default.
• W2012036721 countsByYear W20120367212020 @default.
• W2012036721 crossrefType "journal-article" @default.
• W2012036721 hasAuthorship W2012036721A5025645999 @default.
• W2012036721 hasAuthorship W2012036721A5053374206 @default.
• W2012036721 hasAuthorship W2012036721A5072599343 @default.
• W2012036721 hasConcept C126322002 @default.
• W2012036721 hasConcept C141071460 @default.
• W2012036721 hasConcept C17744445 @default.
• W2012036721 hasConcept C199539241 @default.
• W2012036721 hasConcept C2779473830 @default.
• W2012036721 hasConcept C2780252810 @default.
• W2012036721 hasConcept C31174226 @default.
• W2012036721 hasConcept C71924100 @default.
• W2012036721 hasConceptScore W2012036721C126322002 @default.
• W2012036721 hasConceptScore W2012036721C141071460 @default.
• W2012036721 hasConceptScore W2012036721C17744445 @default.
• W2012036721 hasConceptScore W2012036721C199539241 @default.
• W2012036721 hasConceptScore W2012036721C2779473830 @default.
• W2012036721 hasConceptScore W2012036721C2780252810 @default.
• W2012036721 hasConceptScore W2012036721C31174226 @default.
• W2012036721 hasConceptScore W2012036721C71924100 @default.
• W2012036721 hasIssue "1" @default.
• W2012036721 hasLocation W20120367211 @default.
• W2012036721 hasLocation W20120367212 @default.
• W2012036721 hasOpenAccess W2012036721 @default.
• W2012036721 hasPrimaryLocation W20120367211 @default.
• W2012036721 hasRelatedWork W2052497673 @default.
• W2012036721 hasRelatedWork W2352247659 @default.
• W2012036721 hasRelatedWork W2354785620 @default.
• W2012036721 hasRelatedWork W2375359181 @default.
• W2012036721 hasRelatedWork W2392422383 @default.
• W2012036721 hasRelatedWork W2586998360 @default.
• W2012036721 hasRelatedWork W2767618185 @default.
• W2012036721 hasRelatedWork W4319770546 @default.
• W2012036721 hasRelatedWork W4324096639 @default.
• W2012036721 hasRelatedWork W3006168697 @default.
• W2012036721 hasVolume "4" @default.
• W2012036721 isParatext "false" @default.
• W2012036721 isRetracted "false" @default.
• W2012036721 magId "2012036721" @default.
• W2012036721 workType "article" @default.